Phase 2 data demonstrated 17.5-month median overall survival in advanced, chemo-refractory patients with microsatellite stable colorectal cancer (MSS-CRC) Company closed $22M financing to support randomized Phase 2b trial; IND cleared and study initiated; Interim results anticipated in late 2026; topline … Read More
News & Blog
Lille, France, October 23, 2025 – LATTICE MEDICAL, a French Medtech company specializing in tissue engineering, announces a Series B fundraising round of €43 million, one of the largest of the year in the French Medtech sector. This major milestone … Read More
Vaxxas secures ~A$90 million in funding to commercialise needle-free vaccination delivery technology
BRISBANE, Australia, Aug. 25, 2025 (GLOBE NEWSWIRE) — Vaxxas Pty Ltd, the biotechnology company pioneering the high-density microarray patch (HD-MAP) for needle-free vaccine delivery, today announced that it has secured ~$90 million in its latest financing round. The financing is … Read More
Case Studies
Discover the insights from the consensus document on Latin America Acne Management, published by experts from SPRIM PRO. This pivotal research highlights how generational shifts are reshaping acne treatment needs, enabling healthcare professionals in Latin America to enhance care for patients. … Read More
A top US-based, multi-national oral care brand seeking to revamp its educational materials to better accommodate the evolving needs of a dental student population now primarily dominated by millennials. … Read More
A leading provider of high-quality, direct-to-consumer (DTC) dietary supplements sought out opportunities to build thought leadership in a rapidly growing market category. As competition increased via the introduction of mediocre players and formulas, a differentiation strategy that focused attention on the importance of quality was critical. … Read More
